Cargando…

Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial

BACKGROUND: Correction surgery for cleft palate is recommended between 9 and 18 months of age. Patients suffer from acute pain after palatoplasty. Clinicians are hesitant to use opioids for analgesia concerning the potential high risk of respiratory adverse events. Intravenous ibuprofen perhaps be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zhe Zhe, Wang, Yan Ting, Zhang, Ma Zhong, Zheng, Ji Jian, Hu, Jie, Zhou, Wan Ru, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532298/
https://www.ncbi.nlm.nih.gov/pubmed/34674670
http://dx.doi.org/10.1186/s12887-021-02907-6
_version_ 1784587038690902016
author Peng, Zhe Zhe
Wang, Yan Ting
Zhang, Ma Zhong
Zheng, Ji Jian
Hu, Jie
Zhou, Wan Ru
Sun, Ying
author_facet Peng, Zhe Zhe
Wang, Yan Ting
Zhang, Ma Zhong
Zheng, Ji Jian
Hu, Jie
Zhou, Wan Ru
Sun, Ying
author_sort Peng, Zhe Zhe
collection PubMed
description BACKGROUND: Correction surgery for cleft palate is recommended between 9 and 18 months of age. Patients suffer from acute pain after palatoplasty. Clinicians are hesitant to use opioids for analgesia concerning the potential high risk of respiratory adverse events. Intravenous ibuprofen perhaps be a suitable adjuvant to pain relief. We try to assess whether preoperative administration of intravenous ibuprofen can decrease opioid requirements following cleft palate repair in infants. METHODS: This single center prospective randomized clinical trial was performed from February to April 2021 at Department of Anesthesiology in Shanghai Children’s Medical Center. Forty patients ASA I-II, aged 9–24 months with isolated cleft palate and undergoing palatoplasty were randomized in a 1:1 ratio to receive either a single dose of 10 mg/kg ibuprofen intravenously or normal saline at induction. Children and infants postoperative pain scale (CHIPPS) was used for pain assessment. Those patients CHIPPS pain score equal or higher than 4 received analgesic rescue with titrating intravenous fentanyl 0.5 μg/kg and repeated in 10 min if required. The primary outcome was the amount of postoperative fentanyl used for rescue analgesia in postanesthesia care unit (PACU). RESULTS: Patients (n = 20 in each group) in IV-Ibuprofen group required less postoperative fentanyl than those in placebo group (p<0.001). There was no significant difference between two groups in first rescue analgesia time (p = 0.079) and surgical blood loss (p = 0.194). No incidence of obvious adverse events had been found within the first 24 h after surgery in both groups. CONCLUSIONS: Preemptive intravenous administration ibuprofen 10 mg/kg at induction had a significant opioid sparing effect in early postoperative period without obvious adverse effects in infants undergoing palatoplasty. TRIAL REGISTRATION: CHICTR, CTR2100043718, 27/02/2021 http://www.chictr.org.cn/showproj.aspx?proj=122187
format Online
Article
Text
id pubmed-8532298
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85322982021-10-25 Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial Peng, Zhe Zhe Wang, Yan Ting Zhang, Ma Zhong Zheng, Ji Jian Hu, Jie Zhou, Wan Ru Sun, Ying BMC Pediatr Research BACKGROUND: Correction surgery for cleft palate is recommended between 9 and 18 months of age. Patients suffer from acute pain after palatoplasty. Clinicians are hesitant to use opioids for analgesia concerning the potential high risk of respiratory adverse events. Intravenous ibuprofen perhaps be a suitable adjuvant to pain relief. We try to assess whether preoperative administration of intravenous ibuprofen can decrease opioid requirements following cleft palate repair in infants. METHODS: This single center prospective randomized clinical trial was performed from February to April 2021 at Department of Anesthesiology in Shanghai Children’s Medical Center. Forty patients ASA I-II, aged 9–24 months with isolated cleft palate and undergoing palatoplasty were randomized in a 1:1 ratio to receive either a single dose of 10 mg/kg ibuprofen intravenously or normal saline at induction. Children and infants postoperative pain scale (CHIPPS) was used for pain assessment. Those patients CHIPPS pain score equal or higher than 4 received analgesic rescue with titrating intravenous fentanyl 0.5 μg/kg and repeated in 10 min if required. The primary outcome was the amount of postoperative fentanyl used for rescue analgesia in postanesthesia care unit (PACU). RESULTS: Patients (n = 20 in each group) in IV-Ibuprofen group required less postoperative fentanyl than those in placebo group (p<0.001). There was no significant difference between two groups in first rescue analgesia time (p = 0.079) and surgical blood loss (p = 0.194). No incidence of obvious adverse events had been found within the first 24 h after surgery in both groups. CONCLUSIONS: Preemptive intravenous administration ibuprofen 10 mg/kg at induction had a significant opioid sparing effect in early postoperative period without obvious adverse effects in infants undergoing palatoplasty. TRIAL REGISTRATION: CHICTR, CTR2100043718, 27/02/2021 http://www.chictr.org.cn/showproj.aspx?proj=122187 BioMed Central 2021-10-22 /pmc/articles/PMC8532298/ /pubmed/34674670 http://dx.doi.org/10.1186/s12887-021-02907-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Peng, Zhe Zhe
Wang, Yan Ting
Zhang, Ma Zhong
Zheng, Ji Jian
Hu, Jie
Zhou, Wan Ru
Sun, Ying
Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
title Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
title_full Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
title_fullStr Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
title_full_unstemmed Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
title_short Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
title_sort preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532298/
https://www.ncbi.nlm.nih.gov/pubmed/34674670
http://dx.doi.org/10.1186/s12887-021-02907-6
work_keys_str_mv AT pengzhezhe preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial
AT wangyanting preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial
AT zhangmazhong preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial
AT zhengjijian preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial
AT hujie preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial
AT zhouwanru preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial
AT sunying preemptiveanalgesiceffectivenessofsingledoseintravenousibuprofenininfantsundergoingcleftpalaterepairarandomizedcontrolledtrial